Total Funding
88
61
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
160070
Satellos specializes in the research and development of drug delivery technologies.
Andrew Rae: President and CEO
John Meekison: Founder & Chief Financial OfficerPast Role: TSX, Chief Financial Officer
About the Company
Satellos Bioscience Inc. is focused on the research and development of drug delivery technologies. By focusing efforts on development instead of research, it's business model aims to acquire the rights to drugs that are either off-patent, currently approved, or near commercialization and develop them by redosing or reformulating them for new
or expanded labels. The subsequent development of these therapeutics may include drug delivery technologies-such as sustained-release or biodegradable matrices to extend patent coverage.
